NeuroMetrix, Inc.
NURO
$4.34
-$0.035-0.80%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -55.77% | -51.19% | -53.55% | -36.60% | -28.67% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -55.77% | -51.19% | -53.55% | -36.60% | -28.67% |
| Cost of Revenue | -52.32% | -34.65% | -48.33% | 3.53% | -23.89% |
| Gross Profit | -57.69% | -60.09% | -56.05% | -54.23% | -31.06% |
| SG&A Expenses | 2.99% | -18.40% | 3.24% | 13.77% | 26.81% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -19.99% | -26.38% | -20.78% | 9.67% | 17.42% |
| Operating Income | -5.40% | 11.16% | -12.64% | -56.34% | -116.82% |
| Income Before Tax | -7.93% | 14.73% | 3.19% | -92.45% | -138.40% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -7.93% | 14.73% | 3.19% | -92.45% | -138.40% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -7.93% | 14.73% | 3.19% | -92.45% | -138.40% |
| EBIT | -5.40% | 11.16% | -12.64% | -56.34% | -116.82% |
| EBITDA | -5.75% | 11.94% | -11.81% | -55.82% | -116.53% |
| EPS Basic | 39.01% | 55.12% | 52.32% | -2.06% | -98.61% |
| Normalized Basic EPS | 40.34% | 52.86% | 41.82% | 17.49% | -122.47% |
| EPS Diluted | 39.01% | 55.12% | 52.32% | -2.06% | -97.35% |
| Normalized Diluted EPS | 40.34% | 52.86% | 41.82% | 17.49% | -122.47% |
| Average Basic Shares Outstanding | 76.97% | 89.98% | 103.04% | 88.57% | 20.04% |
| Average Diluted Shares Outstanding | 76.97% | 89.98% | 103.04% | 88.57% | 20.04% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |